DPIIT recognised startup Government of India
Startup India
Purb Pharma Private Limited - pharma in Sangli, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹50.82 Lakh
▲ 102% YoY
Net profit · FY 2023
₹4.62 Lakh
Net margin 9.1%
EBITDA · FY 2023
₹6.58 Lakh
EBITDA margin 12.9%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹15 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Employees · EPFO
14
Provident fund records
Directors on board
5
As per MCA filings
About Purb Pharma Private Limited
Data last updated:
Purb Pharma Private Limited is a private limited company based in Sangli, Maharashtra, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24239PN2019PTC182828. Its GSTIN is 27AAKCP4314M1Z3 (Maharashtra).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Vijay Dattatray Sawant and Rishikesh Abhaykumar Shirote.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Near Lic Colony Vishrambag, Sangli, Maharashtra, India – 416416.
As per the financials filed for FY 2023, the company reported a revenue of ₹50.82 Lakh, a growth of 102% compared to the previous year. For the same year it recorded a net profit of ₹4.62 Lakh (net margin 9.1%) and EBITDA of ₹6.58 Lakh (EBITDA margin 12.9%).
The company has about 14 employees on its provident fund (EPFO) records.
Court records list 4 cases involving the company, including 4 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website purbpharma.com.
Company details
CIN U24239PN2019PTC182828
Registration Number 182828
Incorporation Date 15 March 2019
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Key People
Vijay Dattatray Sawant Director Rishikesh Abhaykumar Shirote Director Ashutosh Shital Chougule Director Recognitions & Rankings of Purb Pharma
Contact details
Purb Pharma Private Limited's registered office is in Sangli, Maharashtra. Its website is purbpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNear Lic Colony Vishrambag, Sangli, Maharashtra, India – 416416
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Purb Pharma Private Limited, buy the company report.
Comprehensive company report
Purb Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Purb Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Purb Pharma Private Limited, buy the company report.
Financials of Purb Pharma Private Limited
FY 2023 filings availablePurb Pharma Private Limited reported revenue of ₹50.82 Lakh (up 102% YoY) for FY 2023.
Revenue · FY 2023
₹50.82 Lakh ▲ 102%
Net profit · FY 2023
₹4.62 Lakh margin 9.1%
EBITDA · FY 2023
₹6.58 Lakh margin 12.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 102%
EBITDA CAGR growth
1 year
▲ 326%
Revenue rose 102% in the latest year. EBITDA rose 326% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.58 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.62 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.9% | ||||
| Net Profit Margin | 9.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Purb Pharma Private Limited, buy the company report.
Board of directors of Purb Pharma Private Limited
Purb Pharma has 5 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijay Dattatray Sawant | Director | 13 Jul 2020 | 6 Years 3 Months | Current |
| Rishikesh Abhaykumar Shirote | Director | 13 Jul 2020 | 6 Years 3 Months | Current |
| Ashutosh Shital Chougule | Director | 13 Jul 2020 | 6 Years 3 Months | Current |
| Pavankumar Vrashabhasen Upadhye | Director | 15 Mar 2019 | 7 Years 7 Months | Current |
| Rahul Ajitkumar Bhande Also directs: Lykos Pharma Private Limited | Director | 15 Mar 2019 | 7 Years 7 Months | Current |
Peer comparison
Purb Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tanuj Trade Private Limited | ₹50.83 Lakh (FY 2023) | 1527.0% | Gaya, Bihar, India | |||
| Venetian Image Private Limited | ₹50.83 Lakh (FY 2025) | 1568.0% | Delhi, India | |||
| Markecho Pharmaceuticals Private Limited | ₹50.83 Lakh (FY 2024) | 17.0% | Andheri, Mumbai, Maharashtra, India | |||
| Shresth Appartment Private Limited | ₹50.82 Lakh (FY 2025) | -18.0% | Kolkata, West Bengal, India | |||
| Sahaj Vishwas Urja Private Limited | ₹50.82 Lakh (FY 2024) | -100.0% | Indore, Madhya Pradesh, India | |||
| Purb Pharma Private Limitedthis company | ₹50.82 Lakh (FY 2023) | ₹4.62 Lakh | 9.1% | 102.0% | 14 | Sangli, Maharashtra, India |
| Hiranwal Projects Private Limited | ₹50.82 Lakh (FY 2023) | 774.0% | Ghaziabad, Uttar Pradesh, India | |||
| Emenem Exim Private Limited | ₹50.81 Lakh (FY 2023) | 2307.0% | Chennai, Tamil Nadu, India | |||
| Endear Pharma Private Limited | ₹50.81 Lakh (FY 2021) | 347.0% | Bijnor, Uttar Pradesh, India | |||
| Sabharwal Project and Construction Private Limited | ₹50.81 Lakh (FY 2023) | Sirmaur, Himachal Pradesh, India | ||||
| Saurabh Tradecom Limited | ₹50.8 Lakh (FY 2021) | 24.0% | Delhi, India |
To see the full peer comparison of Purb Pharma Private Limited, buy the company report.
Legal cases
Purb Pharma Private Limited has 4 court cases on record: 4 filed against it. 2 cases are pending and 2 are disposed.
Total cases
4
Filed against the company
4
Pending
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 4 | 2 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Civil suit | Filed against the company by HDB Financial Services Ltd Through Its Authorzed Represantative Mr Ankush Ramchandra Mhatugade | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed against the company by Cholamandalam Investment and Finance Company Limited Through Its Ar Vaibhav Mahadeo Kale | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SUMMARY CASE) | Filed against the company by Idfc First Bank Ltd | Disposed |
| District court, Sangli, Maharashtra | Civil suit | Filed against the company by State Bank of India On Behalf of Branch Manager Naik Yogesh Ganesh | Pending |
To see the full case history of Purb Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Purb Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Purb Pharma Private Limited has a workforce of 14 employees on its EPFO records as of Apr 01, 2024, across 1 active EPFO establishment.
Employee count
14
Active EPFO establishments
1
Employee growth
-26.32%
GST
Purb Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAKCP4314M1Z3 | Maharashtra | Active | 13 Oct 2020 |
To see the full GST registrations and return filing status of Purb Pharma Private Limited, buy the company report.
Recent activity
Purb Pharma Private Limited has 11 board changes on record since 2019: 6 appointments and 5 cessations. The latest: Ashutosh Shital Chougule ceased to be Additional Director on 31 Dec 2020.
AGM
Purb Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Purb Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Pune.
Ceased
Ashutosh Shital Chougule ceased to be Additional Director.
Ceased
Rishikesh Abhaykumar Shirote ceased to be Additional Director.
Ceased
Shital Abhinandan Bhosale ceased to be Additional Director.
Ceased
Smita Harshal Patil ceased to be Additional Director.
Ceased
Vijay Dattatray Sawant ceased to be Additional Director.
Appointed
Ashutosh Shital Chougule was appointed as Director.
Appointed
Rishikesh Abhaykumar Shirote was appointed as Director.
Appointed
Shital Abhinandan Bhosale was appointed as Director.
Appointed
Vijay Dattatray Sawant was appointed as Director.
Appointed
Pavankumar Vrashabhasen Upadhye was appointed as Director.
2 earlier events are in the company report.
Frequently asked questions
Purb Pharma is an active private limited company based in Sangli, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 March 2019 (7+ years old) and is registered under CIN U24239PN2019PTC182828.
Purb Pharma has 5 current directors:
- Vijay Dattatray Sawant - Director
- Rishikesh Abhaykumar Shirote - Director
- Ashutosh Shital Chougule - Director
- Pavankumar Vrashabhasen Upadhye - Director
- Rahul Ajitkumar Bhande - Director
The latest financial statements of Purb Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Purb Pharma is 27AAKCP4314M1Z3, registered in Maharashtra.
The CIN (Corporate Identification Number) of Purb Pharma is U24239PN2019PTC182828. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Purb Pharma has 4 court cases on record: 4 filed against it. 2 are pending.
Purb Pharma was incorporated on 15 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Purb Pharma by revenue are Tanuj Trade Private Limited, Venetian Image Private Limited, Markecho Pharmaceuticals Private Limited, Shresth Appartment Private Limited, Sahaj Vishwas Urja Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Ashutosh Shital Chougule ceased to be Additional Director on 31 Dec 2020. Rishikesh Abhaykumar Shirote ceased to be Additional Director on 31 Dec 2020. Shital Abhinandan Bhosale ceased to be Additional Director on 31 Dec 2020. Purb Pharma has 11 board changes on record in total.
Yes, Purb Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Purb Pharma can be reached through the website purbpharma.com. Its registered office is in Sangli, Maharashtra, India.